7037ma - 7037 lithium grease - united states 2008-8-14.pmd
PRODUCT: Crown Lithium Grease aterial Safety Data Sheet SECTION III - PHYSICAL / CHEMICAL CHARACTERISTICS BOILING POINT: N/A SPECIFIC GRAVITY (H20=1, @70°F): 0.66 VAPOR DENSITY: Heavier than air SOLUBILITY IN WATER: Negligible EVAPORATION RATE: Slower than Ether APPEARANCE AND ODOR: Tan / Hydrocarbon Odor
TO: MSDS USERSPlease find below the material safety data sheet as per your request. SECTION IV - FIRE AND EXPLOSION HAZARD DATA
The information presented in these forms is believed to be correct and sufficient to meet the requirements of OSHA Hazard Communication
FLASH POINT: < 0° F (-18° C) METHOD USED: Estimated FLAMMABLE LIMITS - LEL: 1.2% UEL: 9.5%
standard (29 CFR 1910.1200) concerning worker's right to know. In order for the information contained in the MSDS to be most helpful
EXTINGUISHING MEDIA: Carbon dioxide, foam, dry chemical.
we recommend that these forms be made available to all those who handle or may otherwise be exposed to the product. SPECIAL FIRE FIGHTING PROCEDURES: Water spray may be used to cool containers exposed to heat or fire to prevent pressure build up. Self-
This MSDS covers the following Aervoe aerosol product.
contained breathing apparatus should be used if product is involved in fire. UNUSUAL FIRE AND EXPLOSION HAZARDS: Treat as cylinders of compressed gas. Closed containers may rupture due to pressure build up from PRODUCT NAME: HMIS CODES: H F R P SECTION V - REACTIVITY DATA STABILITY: Stable CONDITIONS TO AVOID: Open flames, sparks, electrical arcs. INCOMPATIBILITY (MATERIALS TO AVOID): Strong oxidizing agents, strong acids or bases. HAZARDOUS DECOMPOSITION OR BY-PRODUCTS: Carbon Monoxide and Carbon Dioxide HAZARDOUS POLYMERIZATION: Will not occur SECTION VI - HEALTH HAZARD DATA INHALATION: Respiratory tract irritant. May cause dizziness, light-headedness and / or headaches. SKIN CONTACT: Prolonged or repeated contact may cause defatting and / or dermatitis. EYE CONTACT: Painful and slight to moderate irritation. SECTION I - MANUFACTURER IDENTIFICATION SKIN ABSORPTION: Very low toxicity. MANUFACTURER’S NAME: Aervoe Industries Inc. ADDRESS: 1198 Mark Circle, Gardnerville, NV 89410 INGESTION: May cause chemical pneumonia if aspirated into the lungs. CARCINOGENICITY: None known IARC MONOGRAPHS: No OSHA REGULATED: No INFORMATION PHONE: 775-782-0100 EMERGENCY PHONE: 1-800-424-9300 TERATOGENICITY: Not established MUTAGENICITY: Not established DATE REVISED: August 14, 2008 REASON REVISED: Updated MEDICAL CONDITION GENERALLY AGGRAVATED BY EXPOSURE: Not established EMERGENCY AND FIRST AID PROCEDURES: INHALATION - Remove from exposure. Seek medical attention if signs/symptoms persist.
SPLASH - (SKIN) Wash affected area with soap & water, remove contaminated clothing, seek medical attention if irritation persists.
SPLASH - (EYES) Flush immediately with water for 15 minutes and see medical attention if irritation persists.
INGESTION - Do NOT induce vomiting. Drink plenty of water. SECTION VII - PRECAUTIONS FOR SAFE HANDLING AND USE SECTION II - HAZARDOUS INGREDIENTS / SARA III INFORMATION STEPS TO BE TAKEN IN CASE MATERIAL IS RELEASED OR SPILLED: Remove all sources of ignition: Flames, sparks, static electricity & OCCUPATIONAL EXPOSURE LIMITS
electrical. Ventilate area, avoid run off into sewer by diking, and soak up with inert absorbent using non-sparking type tools. WASTE DISPOSAL METHOD: Dispose of in accordance with local, state and federal regulations. Do not incinerate closed containers. PRECAUTIONS TO BE TAKEN IN HANDLING AND STORING: Do not store above 120° F (49° C). Do not store or use near heat, sparks or flame. OTHER PRECAUTIONS: Do not get in eyes. Do not breathe vapors. Avoid skin contact. Do not take internally. Smoking while using this product SECTION VIII - CONTROL MEASURES RESPIRATORY PROTECTION: Respiratory protection program should be in accordance with 29 CFR 1910.134. VENTILATION: All application areas should be adequately ventilated in order to keep the items in SECTION II below their exposure limits. PROTECTIVE GLOVES: Polyethylene or Neoprene gloves are recommended. EYE PROTECTION: Safety glasses with side shields are recommended. OTHER PROTECTIVE CLOTHING OR EQUIPMENT: Not established. WORK / HYGIENIC PRACTICES: Avoid prolonged or repeated contact. Do not breathe vapors. Wash contaminated clothing prior to reuse. SECTION IX - DISCLAIMER
THE INFORMATION CONTAINED HEREIN IS BELIEVED TO BE ACCURATE BUT IS NOT WARRANTED TO BE SO. NOTHING CONTAINED
***No toxic chemical(s) subject to the reporting requirements of section 313 of Title III and of 40 CFR 372 are present.***
HEREIN CONSTITUTES A SPECIFICATION NOR IS IT INTENDED TO WARRANT SUITABILITY FOR THE INTENDED USE. NOTE: N/A applies to not available or not applicable
Neurology Medical Group of Diablo Valley 400 Taylor Blvd. Ste 301 Pleasant Hill, CA 94523 Phone: 925-602-7060 Janet F. Hornstein Lin , MD Certifications American Board of Psychiatry and Neurology - Neurology (Diplomate) National Board of Medical Examiners (Diplomate) Licensure Academic Degrees MD - New Jersey College of Medicine & Dentistry, Newark, NJ BA - Lite
Was ist bei Kindern zu berücksichtigen? Gebrauchsinformation Zur Anwendung von Neuroplant® 300 mg N liegen keine ausreichenden Untersuchungen vor. Lesen Sie die gesamte Packungsbeilage/Gebrauchsinformation sorgfältig Es darf deshalb bei Kindern unter 12 Jahren nicht angewendet werden. durch, bevor Sie mit der Einnahme dieses Arzneimittels beginnen. 2.2 Besondere Vorsicht